We explored the relationship between NLR and grade 3 or higher treatment related small bowel
toxicity and treatment outcome of patients with rectal cancer undergoing capecitabine and
concurrent intensity modulated radiotherapy (IMRT).
Radiation: capecitabine and concurrent intensity modulated radiotherapy
We will connect you to the doctor responsible for this trial and help you get more information.
Locations near you
Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Full eligibility criteria for NCT03015168
Ages eligible for Study
18 Years to 80 Years
Genders eligible for Study
Accepts Healthy Volunteers
Patients with locally advanced rectal cancer who received neoadjuvant or adjuvant chemoradiotherapy at our hospital were enrolled in this study.
Patients with coexistent autoimmune diseases, infectious diseases, and lacking baseline blood test records were excluded from this study
All locations for NCT03015168
General Hospital of Ningxia Medical University
Yinchuan, Ningxia, China, 750004
View full eligibility
Tris trial is registered with FDA with number: NCT03015168. The sponsor of the trial is General Hospital of Ningxia Medical University and it is looking for 117 volunteers for the current phase.
Official trial title: Prognostic Value of Neutrophil-to-lymphocyte Ratio (NLR) on Rectal Cancer Patients Who Received Capecitabine and Concurrent Intensity Modulated Radiotherapy (IMRT)
1What's a trial
4Get in touch
What's a trial
Not sure you're well informed about clinical trials? Learn more about their benefits, risks and other important details.
Enter your details like condition, age, gender and other preferences and we will show you a list of all relevant clinical trials.
Review the summary of the selected clinical trial and all the locations near you in order to see if it's of interest to you.
Get in touch
You've found an interesting trial? We'll need a bit more information about you so we can connect you to the doctor in charge.
Some people want to consult their doctor before considering participation in a clinical trial. This is absolutely normal as your doctor should know your medical history and should be able to advise you. If you want you can easily share the information for this trial with your doctor by clicking on the button below.